[KTTA] QoQ Quarter Result on 30-Jun-2023 [#Q2]

Stock
[KTTA] Pasithea Therapeutics Corp.
Announcement Date
11-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- 98.63%
YoY- -107.33%
Quarter Report
KTTA's Result
KTTA's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 0 976 0 0 0 241 219 -
PBT -3,861 -5,031 -3,613 -3,598 -3,266 -5,118 -4,191 -5.31%
Tax 0 17 -162 -65 271,869 -1,215 730 -
NP -3,861 -5,048 -3,613 -3,763 -275,135 -3,902 -4,586 -10.82%
Tax Rate - - - - - - - -
Total Cost 3,861 6,024 3,613 3,763 275,135 4,143 4,805 -13.55%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin 0.00 -517.07 0.00 0.00 0.00 -1,621.19 -2,097.88 -
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
EPS -3.70 -4.85 -2.87 -2.88 -211.05 -3.00 -3.45 4.76%
EPS Diluted -3.70 -4.85 -2.87 -2.88 -211.05 -3.00 -3.45 4.76%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.